To include your compound in the COVID-19 Resource Center, submit it here.

Heptares partners with Juntendo University

Heptares Therapeutics, a subsidiary of Sosei Group

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE